Damora Therapeutics Inc. monthly returns
Damora Therapeutics Inc. has averaged 0.63% per month, positive in 41% of months. Month-by-month returns for Damora Therapeutics Inc. (DMRA) below, through October 27, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Damora Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | +3.2% | |
| Sep 2026 | -24.5% | |
| Aug 2026 | -2.8% | |
| Jul 2026 | +11.5% | |
| Jun 2026 | +4.5% | |
| May 2026 | -3.0% | |
| Apr 2026 | -0.9% | |
| Mar 2026 | -12.4% | |
| Feb 2026 | +12.8% | |
| Jan 2026 | +14.0% | |
| Dec 2025 | +29.4% | |
| Nov 2025 | +142.9% | |
| Oct 2025 | +96.8% | |
| Sep 2025 | +17.0% | |
| Aug 2025 | -3.3% | |
| Jul 2025 | -3.5% | |
| Jun 2025 | +11.1% | |
| May 2025 | +9.6% | |
| Apr 2025 | -9.7% | |
| Mar 2025 | -29.2% | |
| Feb 2025 | -11.7% | |
| Jan 2025 | +6.7% | |
| Dec 2024 | -12.3% | |
| Nov 2024 | -22.6% | |
| Oct 2024 | -43.6% | |
| Sep 2024 | +1.7% | |
| Aug 2024 | -15.2% | |
| Jul 2024 | +19.0% | |
| Jun 2024 | -22.0% | |
| May 2024 | -10.1% | |
| Apr 2024 | -13.3% | |
| Mar 2024 | +8.3% | |
| Feb 2024 | +17.6% | |
| Jan 2024 | -15.0% | |
| Dec 2023 | +14.3% | |
| Nov 2023 | +18.9% | |
| Oct 2023 | -26.4% | |
| Sep 2023 | +19.0% | |
| Aug 2023 | -80.4% | |
| Jul 2023 | +22.2% | |
| Jun 2023 | +15.6% | |
| May 2023 | +23.9% | |
| Apr 2023 | -11.6% | |
| Mar 2023 | -9.1% | |
| Feb 2023 | -4.8% | |
| Jan 2023 | +100.0% | |
| Dec 2022 | -26.8% | |
| Nov 2022 | -21.9% | |
| Oct 2022 | +6.3% | |
| Sep 2022 | -12.1% | |
| Aug 2022 | +33.5% | |
| Jul 2022 | -6.9% | |
| Jun 2022 | +32.1% | |
| May 2022 | -22.0% | |
| Apr 2022 | -23.6% | |
| Mar 2022 | +18.9% | |
| Feb 2022 | -22.9% | |
| Jan 2022 | -20.8% | |
| Dec 2021 | +7.4% | |
| Nov 2021 | -14.5% | |
| Oct 2021 | -8.1% | |
| Sep 2021 | -19.3% | |
| Aug 2021 | +3.7% | |
| Jul 2021 | -15.2% | |
| Jun 2021 | -4.7% | |
| May 2021 | -7.2% | |
| Apr 2021 | -5.8% | |
| Mar 2021 | -41.5% | |
| Feb 2021 | -16.1% | |
| Jan 2021 | -1.0% | |
| Dec 2020 | -18.3% | |
| Nov 2020 | +2.1% |
Monthly total return (since Nov 2021)#
Damora Therapeutics Inc. returns by calendar month#
Every month of every year since 2021, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: +3.20% — 3rd of 6 Octobers since 2021 at the last close; the average October returned +5.0%.
| Month | −145%0+145% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +14.0% | +2.9% | 50% | +100.0% 2023 | -20.8% 2022 | |
| Feb | -4.2% | -8.2% | 33% | +17.6% 2024 | -22.9% 2022 | |
| Mar | -10.8% | -10.8% | 33% | +18.9% 2022 | -41.5% 2021 | |
| Apr | -10.8% | -10.6% | 0% | -0.9% 2026 | -23.6% 2022 | |
| May | -1.5% | -5.1% | 33% | +23.9% 2023 | -22.0% 2022 | |
| Jun | +6.1% | +7.8% | 67% | +32.1% 2022 | -22.0% 2024 | |
| Jul | +4.5% | +4.0% | 50% | +22.2% 2023 | -15.2% 2021 | |
| Aug | -10.7% | -3.1% | 33% | +33.5% 2022 | -80.4% 2023 | |
| Sep | -3.0% | -5.2% | 50% | +19.0% 2023 | -24.5% 2026 | |
| Oct | +5.0% | -8.1% | 40% | +96.8% 2025 | -43.6% 2024 | |
| Nov | +20.5% | -14.5% | 40% | +142.9% 2025 | -22.6% 2024 | |
| Dec | +2.4% | +7.4% | 60% | +29.4% 2025 | -26.8% 2022 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from DMRA's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Damora Therapeutics Inc.'s average monthly return?
- Damora Therapeutics Inc. (DMRA) has averaged about 0.63% per month, positive in roughly 41% of months. The best month was Nov 2025 (+142.9%) and the worst was Aug 2023 (-80.4%).